Fierce Pharma Asia—Lilly-Abbisko cardiometabolic pact; Daiichi Sankyo asset sale; Eisai’s next Alzheimer’s prospect
Fierce Pharma Asia—Lilly-Abbisko cardiometabolic pact; Daiichi Sankyo asset sale; Eisai’s [...]
Ogilvy Health’s new creative chief Hessel reflects on pharma’s pandemic opportunities
Ogilvy Health’s new creative chief Hessel reflects on pharma’s pandemic [...]
Blueprint promotes two more execs to C-suite as it looks to realize Ayvakit’s potential
Blueprint promotes two more execs to C-suite as it looks [...]
Viatris yanks one batch of diabetes med Semglee because of missing label risks
Viatris yanks one batch of diabetes med Semglee because of [...]
Merck scores a win in $1.4B insurance fight over devastating cyberattack
Merck scores a win in $1.4B insurance fight over devastating [...]
UCB buys rare disease drugmaker Zogenix for up to $1.9B, bolstering its epilepsy position
UCB buys rare disease drugmaker Zogenix for up to $1.9B, [...]
FDA extends decision dates on bluebird bio’s gene therapy drugs beti-cel and eli-cel by 3 months
FDA extends decision dates on bluebird bio’s gene therapy drugs [...]
Inside the Catalent FDA citation said to trigger Novo Nordisk’s Wegovy supply hiccup
Inside the Catalent FDA citation said to trigger Novo Nordisk’s [...]
Hikma shells out $45.75M to buy bankrupt Teligent’s Canadian assets
Hikma shells out $45.75M to buy bankrupt Teligent’s Canadian assets [...]
Shkreli hit with $64.6M verdict, lifetime pharma ban in antitrust case
Shkreli hit with $64.6M verdict, lifetime pharma ban in antitrust [...]